Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1132429

	registered interest
	date	17/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Genomics
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when the NHS Genomic Medicine Service will begin performing whole genome sequencing.
	tabling member constituency	Totnes
	tabling member printed	Dr Sarah Wollaston
	uin	265510
	answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>As part of the NHS Long Term Plan, the National Health Service has committed to sequencing 500,000 whole genomes by 2023/24.</p><p>During 2019, the NHS will begin to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test; and</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and Acute Myeloid Leukaemia.</p><p> </p><p>As the price of whole genome sequencing falls and the evidence improves, we envisage that it will be extended to more conditions and therefore more patients.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 265508 265509 question first answered 20/06/2019 15:34:08 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4073 label Biography information for Dr Sarah Wollaston

760705

	registered interest
	date	14/09/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Genomics
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to the Answer of 13 September 2017 to Question 8799, on genetics: screening, in what locations other than Cambridge NHS genome testing will take place.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	105166
	answer	answer is ministerial correction date of answer 10/10/2017 answer text <p>NHS England is currently preparing to procure a network of genomic laboratory hubs to provide comprehensive coverage across the country. The process is currently in the pre-procurement phase and therefore the defined geographies for these hubs have not yet been confirmed.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 10/10/2017 13:00:31 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4124 label Biography information for Chi Onwurah

757689

	registered interest
	date	05/09/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Genomics
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what estimate he has made of trends in the level of employment in (a) Cambridge and (b) the rest of the UK as a result of the decision to centralise genome testing in Cambridge.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	8802
	answer	answer is ministerial correction date of answer 13/09/2017 answer text <p>NHS England has no knowledge of the decision to centralise all National Health Service genomic testing in Cambridge that is being referred to and therefore no assessment has been made. Whole genome sequencing is being carried out in Cambridge by Illumina for the 100,000 Genomes Project.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 13/09/2017 15:47:48 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4124 label Biography information for Chi Onwurah

156468

	registered interest
	date	18/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Genomics
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether, in view of developments in genomic medicine and the case for communicating accurately and sensitively the significance of genomic data to patients, they will reconsider the possibility of mandatory registration of genomic counsellors.
	tabling member printed	Lord Walton of Detchant
	uin	HL2910
	answer	answer is ministerial correction date of answer 02/12/2014 answer text <p>The Government has emphasised the importance of developing a well-trained National Health Service work force to benefit from the advances in genomic medicine. The education and training requirements of genetic counsellors and their regulatory arrangements are currently being considered as part of the Health Education England’s Genomics Programme. NHS England is focused on ensuring it fulfils its contribution to meeting the objectives of the 100,000 Genomes Project and the elements for which it is accountable. This includes establishing NHS Genomic Medicine Centres through a robust procurement process, as part of which all potential NHS Genomic Medicine Centres will be required to demonstrate what arrangements they will put in place to ensure validated findings are fed back to patients in an appropriate and timely manner.</p><p> </p> answering member printed Earl Howe question first answered 02/12/2014 12:39:09 answering member 2000 label Biography information for Earl Howe
	tabling member	1716 label Biography information for Lord Walton of Detchant